ConductScience.org, home

Paper24722151

National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer.

Patel AP and 12 others. J Thorac Oncol, 2014. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer. Papers, record 24722151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24722151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
National patterns of care and outcomes after combined modality therapy for stage IIIA non-small-cell lung cancer.
PubMed
Journal
J Thorac Oncol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2022-04-09
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Patel APAalok P
2Crabtree TDTraves D
3Bell JMJennifer M
4Guthrie TJTracey J
5Robinson CGClifford G
6Morgensztern DDaniel
7Colditz GAGraham A
8Kreisel DDaniel
9Krupnick ASA Sasha
10Bradley JDJeffrey D
11Patterson GAG Alexander
12Meyers BFBryan F
13Puri VVarun

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
ChemoradiotherapyMajor topic
Lung NeoplasmsMajor topic
PneumonectomyMajor topic
Aged
Antineoplastic Agents
Chemoradiotherapy, Adjuvant
Female
Humans
Length of Stay
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Practice Patterns, Physicians'
Radiotherapy Dosage
Survival Rate
Treatment Outcome
United States

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K07 CA178120NCI NIH HHSUnited StatesK07CA178120PubMed and NIHNIH RePORTER
K12 CA167540NCI NIH HHSUnited StatesK12CA167540PubMed and NIHNIH RePORTER
K12CA167540-02NCI NIH HHSUnited StatesK12CA167540PubMed and NIHNIH RePORTER
K07CA178120NCI NIH HHSUnited StatesK07CA178120PubMed and NIHNIH RePORTER

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117599507Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.J Thorac Cardiovasc Surg2007https://conductscience.org/library/papers/17599507PubMed
218670305Gaps in optimal care for lung cancer.J Thorac Oncol2008https://conductscience.org/library/papers/18670305PubMed
323401449New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.J Clin Oncol2013https://conductscience.org/library/papers/23401449PubMed
417451842National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care.Lung Cancer2007https://conductscience.org/library/papers/17451842PubMed
519551884Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.Cancer2009https://conductscience.org/library/papers/19551884PubMed
619632716Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.Lancet2009https://conductscience.org/library/papers/19632716PubMed
721903745Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.J Natl Cancer Inst2011https://conductscience.org/library/papers/21903745PubMed
820100967
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
J Clin Oncol2010https://conductscience.org/library/papers/20100967PubMed
919875976Multimodality treatment of stage III non-small cell lung cancer: analysis of a phase II trial using preoperative cisplatin and gemcitabine with concurrent radiotherapy.J Thorac Oncol2009https://conductscience.org/library/papers/19875976PubMed
1020416887Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.J Thorac Cardiovasc Surg2010https://conductscience.org/library/papers/20416887PubMed
1115908042
A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer.
Lung Cancer2005https://conductscience.org/library/papers/15908042PubMed
1212142202Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: an analysis of 350 operated patients.Eur J Cardiothorac Surg2002https://conductscience.org/library/papers/12142202PubMed
1322233799Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?Eur J Cardiothorac Surg2012https://conductscience.org/library/papers/22233799PubMed
1421620372Neoadjuvant chemoradiation for clinically advanced non-small cell lung cancer: an analysis of 233 patients.Ann Thorac Surg2011https://conductscience.org/library/papers/21620372PubMed
1518779622Racial composition of hospitals: effects on surgery for early-stage non-small-cell lung cancer.J Clin Oncol2008https://conductscience.org/library/papers/18779622PubMed
1617762335
The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.
J Thorac Oncol2007https://conductscience.org/library/papers/17762335PubMed
1723393428Socioeconomic inequalities in lung cancer treatment: systematic review and meta-analysis.PLoS Med2013https://conductscience.org/library/papers/23393428PubMed
1822982648Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.J Thorac Oncol2012https://conductscience.org/library/papers/22982648PubMed
1922386614Cardiac surgery in patients with a history of malignancy: increased complication rate but similar mortality.Heart Lung Circ2012https://conductscience.org/library/papers/22386614PubMed
2019049763Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes.Ann Thorac Surg2008https://conductscience.org/library/papers/19049763PubMed

See all 30 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
36997606Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan.Sci Rep2023https://conductscience.org/library/papers/36997606PubMed
36172417Surgical decision-making in advanced-stage non-small cell lung cancer is influenced by more than just guidelines.JTCVS Open2022https://conductscience.org/library/papers/36172417PubMed
36004217Select octogenarians with stage IIIa non-small cell lung cancer can benefit from trimodality therapy.JTCVS Open2022https://conductscience.org/library/papers/36004217PubMed
33777572Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting.Cureus2021https://conductscience.org/library/papers/33777572PubMed
31372055Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study.Cancer Manag Res2019https://conductscience.org/library/papers/31372055PubMed
31220530Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.Semin Thorac Cardiovasc Surg2020https://conductscience.org/library/papers/31220530PubMed
30710323
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules: analysis of the ESPATUE randomized phase 3 trial.
Eur J Nucl Med Mol Imaging2019https://conductscience.org/library/papers/30710323PubMed
30626407Trimodally treatment for stage IIIa NSCLC patients increases survival while not effecting surgical mortality or complexity.J Cardiothorac Surg2019https://conductscience.org/library/papers/30626407PubMed
30551965Survival benefits associated with surgery for advanced non-small cell lung cancer.J Thorac Cardiovasc Surg2019https://conductscience.org/library/papers/30551965PubMed
28964421A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients.Ann Thorac Surg2017https://conductscience.org/library/papers/28964421PubMed
28924214Low Frequency Magnetic Fields Induce Autophagy-associated Cell Death in Lung Cancer through miR-486-mediated Inhibition of Akt/mTOR Signaling Pathway.Sci Rep2017https://conductscience.org/library/papers/28924214PubMed
28532544[Progress of Neoadjuvant Therapy Combined with Surgery in Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi2017https://conductscience.org/library/papers/28532544PubMed
28203400Treatment of resectable stage IIIA non-small cell lung cancer.J Thorac Dis2017https://conductscience.org/library/papers/28203400PubMed
28110809Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer.Ann Thorac Surg2017https://conductscience.org/library/papers/28110809PubMed
27293147Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival.Ann Thorac Surg2016https://conductscience.org/library/papers/27293147PubMed
26410162Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.Ann Thorac Surg2016https://conductscience.org/library/papers/26410162PubMed
26319488The Role of Surgical Resection in Stage IIIA Non-Small Cell Lung Cancer: A Decision and Cost-Effectiveness Analysis.Ann Thorac Surg2015https://conductscience.org/library/papers/26319488PubMed
26228601Multidisciplinary Treatment for Stage IIIA Non-Small Cell Lung Cancer: Does Institution Type Matter?Ann Thorac Surg2015https://conductscience.org/library/papers/26228601PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24722151

GET https://conductscience.org/api/papers/v1/24722151/references?page=2